A post-hoc analysis of the phase 3b JUMP trial found that ruxolitinib plus anemia supportive care maintained efficacy and reduced transfusion needs in patients with myelofibrosis.

A post-hoc analysis of the phase 3b JUMP trial assessed outcomes in patients with myelofibrosis and baseline anemia who were treated with ruxolitinib alongside anemia-supportive therapies, according ...

A European Space Agency-led effort is helping marine scientists identify and characterize the most biologically vulnerable ...

Most of us have seen a service dog or a therapy cat making the rounds and raising morale. However, can other pets also be ...

During a live event, Thomas LeBlanc, MD, MA, discussed the outcomes of the COMMANDS trial of luspatercept in myelodysplastic ...

Person-centered therapy, also known as Rogerian therapy or client-based therapy, employs a non-authoritative approach that allows clients to take more of a lead in sessions such that, in the ...

In recent years, however, several newer systemic therapy options have shown efficacy in the first- and second-line settings, including evidence of the effectiveness of combination therapy. 12-14 These ...

New findings reveal that combining erythropoiesis-stimulating agents with ruxolitinib maintains efficacy in treating ...

News; US News; Solar eclipse; Incredible moment ESA satellites move within single millimetre to create man-made eclipse The European Space Agency has spearheaded a £154 million effort to ...

A pair of European satellites have created the first artificial solar eclipses by flying in precise and fancy formation, providing hours of on-demand totality for scientists.Related video above ...